ETHIBOND EXTRA & EXCEL POLYESTER SUTURE UNKNOWN
Report
- Report Number
- 2210968-2018-75492
- Event Type
- Injury
- Date Received
- August 28, 2018
- Report Date
- August 16, 2018
- Manufacturer
- ETHICON INC.
- Product Code
- GAT
- PMA / PMN Number
- K946173
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
(B)(4). ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ETHICON PRODUCT (ETHIBOND SUTURE) INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH THE ETHICON PRODUCT (ETHIBOND SUTURE) USED IN THIS PROCEDURE? CITATION: HERNIA (2017) 21:291¿298; DOI 10.1007/S10029-016-1486-6 (B)(4).
IT WAS REPORTED VIA JOURNAL ARTICLE: "TITLE: LONG-TERM RESULTS AND COMPLICATIONS RELATED TO CRURASOFT MESH REPAIR FOR PARAESOPHAGEAL HIATAL HERNIAS" AUTHOR(S): P. PRIEGO , J. PEREZ DE OTEYZA , J. GALINDO , P. CARDA1 , F. GARCI´A-MORENO , G. RODRI´GUEZ VELASCO , E. LOBO CITATION: HERNIA (2017) 21:291¿298; DOI 10.1007/S10029-016-1486-6 THE AIM OF THIS STUDY IS TO PRESENT OUR LONG-TERM RESULTS AND COMPLICATIONS RELATED TO CRURASOFT MESH (BARD) FOR THE TREATMENT OF LARGE AND PARAESOPHAGEAL HIATAL HERNIAS (LPHH). FROM JAN2004 TO DEC2014, 93 PATIENTS WITH GASTROESOPHAGEAL DISEASE OR LPHH UNDERWENT OPEN OR LAPAROSCOPIC FUNDOPLICATION WHERE PRIMARY SIMPLE SUTURE OF THE CRURA AND ADDITIONAL REINFORCEMENT WITH A CRURASOFT MESH (BARD) WERE PERFORMED. IN THIS TECHNIQUE, PRIMARY UROPLASTY WAS PERFORMED USING THREE-FOUR INTERRUPTED 0 ETHIBOND SUTURES; MESH WAS FIXED WITH 2-0 ETHIBOND SUTURES (N=91) AND AUTOSUTURE PROTACK (N=2); A ¿¿FLOPPY¿¿ NISSEN FUNDOPLICATION (N=86) WAS THEN TAILORED IN ALL THE PATIENTS USING THREE 2¿0 ETHIBOND STITCHES. EARLY COMPLICATIONS INCLUDED WOUND INFECTION (N=1) AND ANEMIA/BLEEDING (N=1). LATE COMPLICATIONS INCLUDED VOMITS AND DYSPHAGIA (N=5), VOMITS (N=3), WOUND BLEEDING (N=1), WOUND INFECTION (N=1) AND PYROSIS (N=1). ADDITIONALLY, A (B)(6) MALE PATIENT HAD REOPERATION OF HERNIA REDUCTION 20 DAYS AFTER THE PROCEDURE DUE TO INCARCERATED RECURRENCE HIATAL HERNIA WITH GASTRIC ISCHEMIA. MOREOVER, A (B)(6) FEMALE PATIENT ALSO HAD REOPERATION OF ESOPHAGOGASTROSTOMY AND JEJUNOSTOMY WITH REMOVAL OF MESH 5 MONTHS POST PROCEDURE DUE TO ESOPHAGEAL PERFORATION WITH MESH INCLUSION. FURTHERMORE, A (B)(6) FEMALE PATIENT ALSO HAD REOPERATION OF HERNIA REDUCTION AND GASTROSTOMY 5 MONTHS POST-SURGERY DUE TO INCARCERATED RECURRENCE HIATAL HERNIA. THE RECURRENCE RATE IN PATIENTS WITH A CRURASOFT (BARD) IS ACCEPTABLE. HOWEVER, THE RATE OF POSTOPERATIVE COMPLICATIONS AND MORTALITY IS EXCESSIVE. THE USE OF MESHES IN THE HIATUS KEEPS ON BEING CONTROVERSIAL DUE TO THE SEVERE COMPLICATIONS RELATED TO THEM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 666081 | ETHIBOND EXTRA & EXCEL POLYESTER SUTURE UNKNOWN | SUTURE, NONABSORBABLE, SYNTHETIC | GAT | ETHICON INC. | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Required Intervention |